Acadian Asset Management
BSTG

Acadian Asset Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

Acadian Asset Management’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-22,369
Closed -$106K – 1115
2013
Q4 		$106K Buy
+22,369
New +$105K ﹤0.01% 877

Other funds holding BSTG

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Acadian Asset Management's BSTG Position: Q1 2014 in Review

Acadian Asset Management sold out of Biostage, Inc. Common Stock (BSTG) in Q1 2014, closing a stake of 22,369 shares — an estimated $106K sold.

Acadian Asset Management first reported a position in BSTG in Q4 2013 and held it in 1 quarter. The position peaked at $106K in Q4 2013. 51 funds tracked by Wall St. Rank hold BSTG as of Q1 2014.

  • Acadian Asset Management reported no remaining Biostage, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Acadian Asset Management sold 22,369 Biostage, Inc. Common Stock shares in Q1 2014, an estimated $106K.
  • Acadian Asset Management first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 1 quarter.
  • Acadian Asset Management's Biostage, Inc. Common Stock position peaked at $106K in Q4 2013.
  • 51 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q1 2014.

Based on Acadian Asset Management's 13F filing for Q1 2014, filed 22 Apr 2014.